InMed Pharmaceuticals Inc - Aset Bersih saben Siji Saham INM

The high barrier to entry in the psychotropic substance sector is driven by strict regulatory controls and biosynthesis patents. A key book value indicator confirms this specificity, where the value of 0.20 expresses the metric level. InMed Pharmaceuticals (INM) develops high-margin ophthalmological drugs from rare cannabinoids; however, the company currently operates on cash reserves as it has no active commercial sales.

INM (InMed Pharma) riwayat Nilai Buku saben Saham saka 04.07.2022 nganti 27.10.2026

inmedpharma.com - rincian analitis lan metrik utama (INM)

- rega lan prakiraan konsensus rega:

Bagan rega InMed Pharma|INM - Target konsensus

- data kapitalisasi pasar:

Nilai pasar InMed Pharmaceuticals Inc.|INM - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham InMed Pharmaceuticals|INM - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku inmedpharma.com|INM - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal InMed Pharmaceuticals|INM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas InMed Pharmaceuticals Inc.|INM - Utang kumulatif perusahaan|Utang marang nilai buku InMed Pharmaceuticals Inc.

Analisis wiwitan perusahaan:INM InMed Pharma

Barang unggulan InMed Pharmaceuticals Inc.

For InMed Pharmaceuticals (INM), the calculated book value per share reflects the biopharmaceutical business's ability to preserve capital amid high clinical trial costs and regulatory risks. This indicator measures the residual value of net assets per share, allowing investors to assess the company's actual tangible asset base and the protection of capital against cash burn rates.

Pesaing InMed Pharmaceuticals (INM)

INDV: Aset Bersih saben Siji Saham|COLL: Nilai Akuntansi saben Saham|Aset Bersih saben Siji Saham Cronos Group Inc.|canopygrowth.com (CGC) - Ekuitas saben Saham|HITI (High Tide) - Nilai Buku saben Saham|Nilai Buku saben Saham ACB|Achieve Life Sciences, Inc (ACHV) - Aset Bersih saben Siji Saham|Nilai Akuntansi Saham Skye Bioscience Inc. (SKYE)|Anebulo Pharmaceuticals - Nilai Buku saben Saham|InterCure Ltd - Nilai Akuntansi saben Saham|NTRB (Nutriband Corp) - Aset Bersih saben Siji Saham|Nasus Pharma Ltd (NSRX) - Nilai Aset Bersih saben Saham|Nilai Akuntansi saben Saham igcinc.us IGC|MIRA Pharmaceuticals, Inc. (MIRA) - Nilai Akuntansi Saham|Nilai Buku saben Saham Flora Growth Corp. FLGC|Nilai Buku Saham IMC|Nilai Buku saben Saham ADIL|Nilai Buku saben Saham ARTL (artelobio.com)|Aset Bersih saben Siji Saham Ensysce Biosciences, Inc.|Titan Pharmaceuticals Inc. - Nilai Akuntansi Saham|GNLN: Aset Bersih saben Siji Saham|AKAN - Nilai Akuntansi saben Saham|Enveric Biosciences, Inc. - Nilai Buku saben Saham|BGXX (Bright Green Corporation) - Aset Bersih saben Saham|Aset Bersih saben Siji Saham Hempacco Co., Inc. (HPCO)